Mountain View, CA-based Glooko and Gothenburg, Sweden-based Diasend have merge into a unified company to create a leading diabetes management platform.
The combined business, which merged under the Glooko name, recently raised $8m in equity financing.
The round was led by Canaan Partners with participation from Social Capital, Samsung Ventures and Yogen Dalal, Glooko’s founder and partner emeritus at venture capital firm Mayfield fund.
The company will use the funds to accelerate integration and sales efforts.
Led by Rick Altinger, CEO, Glooko provides a platform that downloads data from more than 160 different devices – including glucose meters, insulin pumps, continuous glucose monitors (CGMs) and activity trackers – to enable support for people with diabetes during and in-between doctor visits, as well as in-office diabetes data uploads and analytics. The company’s products also include smartphone enabled self-management and a population health platform that supports diabetes coaches around the world.
The combined business now enables in-clinic and remote diabetes management across 4,000 diabetes health systems, 23 countries and 15 languages worldwide.